Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin/Metronidazole vs Amoxicillin/Clarithromycin Quadruple Therapy for H. pylori
NCT02175901Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jul 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metronidazole in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Eradication rate of Helicobacter pylori at 2 months. Started Jul 2014; status: completed.
02
Drugs
metronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02175901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175901.